• Backcountry aviation innovator CubCrafters is advancing its ability to respond to customers of its popular XCub and other aircraft products by welcoming outside investors
• CubCrafters’ public investment offering was initially introduced last year through a Reg A+ filing qualified by the FTC in November, at which point more than $26 million of its $50 million goal had already been reserved pre-offering
• The company announced Jan. 17 that it has expanded that investment opportunity to residents in Florida, New Jersey, Texas, and Washington, through a Regulation CF campaign serving non-accredited investors who couldn’t qualify under the Reg A+ program
• Both investment offerings offer the same terms — $5 per share and a minimum investment of $400

The introduction of a new Regulation CF campaign by Yakima, Wash.-based aviation company CubCrafters has helped the best-in-class backcountry aircraft producer clear a critical hurdle to accepting investments from non-accredited investors in several states as a result of local restrictions in those states.

The allowance for investment from non-accredited investors living in Florida, New Jersey, Texas and Washington means it is now possible for investors in every state to participate in CubCrafters’ public offering if they wish.

“Our fans, customers, aviation enthusiasts, employees, and even the general public in the states of Florida, New Jersey, Texas, and Washington have told us that they very much want to participate in this investment opportunity,” CubCrafters President and CEO Patrick Horgan stated in the company’s news release (https://ibn.fm/lWwS4). “It was always our intention for everyone to be able to participate in our offering regardless of their location, and now they can.”

CubCrafters unveiled its plans to become a publicly funded company in July with an announcement that it would accept reservations for preferred stock under a Reg A+ filing, and in November Horgan announced the Federal Trade Commission (“FTC”) qualified the Reg A+ filing, opening the door for the investors to come onboard (https://ibn.fm/8OdXy).

The new Regulation CF campaign offers the same terms for preferred stock to the public — an initial price of $5 per share and a minimum investment of $400, according to the company.

The company aims to raise up to $50 million and had already received reservations for more than $26 million of its shares within 90 days of its announcement it would accept outside investment for the first time.

CubCrafters builds popular FAA-certified aircraft, light sport airplanes that meet international air traffic flow management (“ATFM”) standards, experimental aircraft for hands-on builders taking advantage of the company’s assistance program, and kits for those prepared to work on their own.

The purpose of the funding drive is to help the company grow sufficiently that it can reduce customers’ wait times (currently booked out at about two years) while also enabling the company to accelerate the pace of innovation to develop faster, more powerful, technically capable aircraft, to improve customer support, and to boost sales in overseas markets where the company flagship XCub aircraft has received international certifications.

Its XCub and Carbon Cub SS models are advanced versions of the legacy Super Cub using current-day technology — a high-performance fixed-wing craft useful for accessing backcountry areas without the need for paved runways, whether for commercial needs or for personal recreation.

The airplanes have lower operational costs than helicopters, which have also made them attractive to the government, leading to a contract with the U.S. Department of Agriculture announced last month to replace some of its aging Piper PA-18 Super Cubs currently in its fleet.

“Our goal here at CubCrafters is to provide them with such a good platform (an aircraft that is more capable, more cost effective, and safer), that they ultimately replace their entire current fleet of around 40 legacy aircraft with the XCub,” Vice President of Sales and Marketing Brad Damm told Flying magazine (https://ibn.fm/1l223).

For more information, visit the company’s website at www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

• MetAlert recently announced the planned acquisition of TrakTec LLC, a Florida-based leader in location awareness technology for consumer and business applications
• The acquisition is expected to add several products to MetAlert’s existing suite of products, one of which is an RFID and Bluetooth-enabled tracking technology called SafetyNet(R)
• The SafetyNet Tracking System comprises the SafetyNet Bracelets that patients wear, and a receiver-antenna combo used by police departments and first responders
• The Chelmsford Police Department in Massachusetts recently reported it had successfully located a missing senior citizen with dementia because of its participation in the SafetyNet program
• The department has, over time, established that radio frequency can be superior to GPS at successfully tracking missing persons, especially in challenging conditions such as densely wooded areas, buildings, basements, and shallow water

MetAlert (OTC: MLRT), a pioneer in smart, mobile, and wearable GPS tracking and recovery location-based products and services, is implementing a solid growth strategy that has seen it enter into a Heads of Terms agreement to acquire TrakTec LLC, a Florida-based leader in location awareness technology for consumer and business applications. Announced January 11, the agreement is expected to close on or before March 17 this year upon completing satisfactory due diligence and audits (https://ibn.fm/uzKUZ).

The acquisition is expected to add iGPS products, namely the Wizard GPS Tracking Watch Phone for children and the Phoenix GPS-based smartwatch for seniors, and SafetyNet(R), a radio-frequency identification (“RFID”) and Bluetooth-enabled tracking technology, to MetAlert’s existing suite of mostly GPS-based tracking products. Of the additions, SafetyNet stands out because of radio frequency’s unique advantages over GPS in certain outdoor environments.

TrakTec’s SafetyNet System comprises bracelets designed to be worn on the wrist or ankles at all times and individually emit a unique signal that represents the wearable’s own RFID. It is this RFID that is then fed into a receiver to enable tracking. The receivers are meant to be operated by law enforcement officials as part of the SafetyNet Tracking Systems program, with the police departments receiving handheld and vehicle-mounted antennas that isolate and boost the RF produced by the bracelets. Generally, the SafetyNet Tracking System is intended to help public safety agencies quickly locate patients with such conditions as autism, Alzheimer’s disease, and dementia.

Once an alert goes out that a SafetyNet user is missing, the first responders whose vehicle is equipped with an antennae head to the missing person’s last known location. This antenna, which isolates the incoming signals from the bracelet, allows the responders to track the location of the missing person up to a proximity of about a quarter of a mile, at which point the responders shift to the handheld tracking device that has a directional antenna. This device enables the responders to further isolate the person’s location and eventually find them.

Since its formation in 2010, SafetyNet has been deployed in more than 1,000 rescue cases (https://ibn.fm/9FU2W) and is utilized by police departments across more than 15 US states (https://ibn.fm/cN3Ws). One of these departments, the Chelmsford Police Department in Massachusetts, recently reported successfully locating a missing senior citizen with dementia because of its participation in the SafetyNet program (https://ibn.fm/N2aHK).

For more information, visit the company’s website at www.MetAlert.com.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

• SILO recently provided status update on its sponsored clinical trial with UCSF examining psilocybin’s effects on inflammation
• Targeted patient populations from study may provide support for development and use of psilocybin as a therapeutic to treat inflammatory conditions
• Data collection from all study groups expected by April 2023
• SILO additionally evaluating its ketamine formulation through its partnership agreement with Zylö Therapeutics

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company that fuses traditional medicine with psychedelics, recently provided a progress update on its sponsored clinical trial with the University of California, San Francisco (“UCSF”) examining the effect of psilocybin on inflammation. Research into psychedelics like psilocybin has recently experienced a renaissance, specifically for treating depression, addiction, anxiety, obsessive-compulsive disorder, and inflammatory diseases (https://ibn.fm/vnsO7). Silo’s sponsored clinical trial with the Clinical & Translational Science Institute at UCSF aims to validate the use of psilocybin as a therapeutic by evaluating the effects of the compound on patients suffering from inflammatory disorders, including Parkinson’s disease, bipolar disorder, and chronic pain. “The UCSF research team is making progress on the clinical trial,” said Eric Weisblum, Chief Executive Officer of Silo Pharma (https://ibn.fm/h7cAA). “The data gathered from these studies could uncover the role of inflammatory activity on such conditions as Parkinson’s, bipolar disorder, and chronic pain. Utilizing psilocybin in this study in a regimented dosing pattern, we hope to gain significant data both in mechanism of action and potential biomarker for personalization of psilocybin therapy.  The targeted patient populations from the study could provide support for the development and use of psilocybin as a therapeutic coupled with our novel homing peptides and topical technology.” The clinical study comprises preparation therapy, two separate dosing sessions with psilocybin, and integration therapy for the three patient populations afflicted with Parkinson’s disease, bipolar disorder, and chronic pain. Blood samples are collected from each patient at four points: one at baseline before treatment begins, one at 24 hours following both dosing sessions, and one after 30 days during a follow-up session. Data collection from the study is expected to be completed by April 2023 for all three patient populations. In addition to its partnership with UCSF, Silo Pharma is also evaluating its ketamine formulation, designated as SPC-14, through a joint partnership agreement with Columbia University (https://ibn.fm/9OQtD). The company initially entered a sponsored pact with the university in October 2021 and has recently extended the contract to continue research for SPC-14 and SPC-15, a targeted therapeutic for stress-induced anxiety disorders (https://ibn.fm/969lZ). Silo Pharma Inc. is fusing traditional therapeutics with psychedelic research to provide novel treatments for numerous indications, including post-traumatic stress disorder (“PTSD”), fibromyalgia, Alzheimer’s disease, Parkinson’s disease, rheumatoid arthritis, and other rare neurological disorders. The company partners with leading institutions such as Columbia University, the University of California San Francisco (“UCSF”), and the University of Maryland, Baltimore (“UMB”) to develop treatments the company believes will transform healthcare and improve patient outcomes. For more information, visit the company’s website at www.SiloPharma.com. NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

• The February 15, 2023 Investor Day virtual event will be hosted by the company’s President and CEO, Brian Haugli, and CFO, Ryan Polk
• Reports have shown an increase in cyberattacks due to the growth in network attack surfaces for in-office and remote workers who rely on cloud environments, mobile devices, software applications, and third-party suppliers to conduct business
• SideChannel’s newest product release, Enclave(TM), is a comprehensive cloud and network solution that enables IT teams to contain breaches faster, reduce network outages, minimize latency, and strengthen overall defensive security

SideChannel (OTCQB: SDCH), a provider of cybersecurity services and technology, develops technologies to make cybersecurity simple and accessible, by matching organizations worldwide with expert virtual Chief Information Security Officers (vCISOs), allowing companies to assess cyber risk and ensure cybersecurity compliance, without jeopardizing financial assets. The company has announced its Investor Day event to be held virtually on February 15, 2023, from 9:00 am to 10:30 am EST (https://ibn.fm/LG5ZY). Investor Day will be hosted by SideChannel’s President and CEO, Brian Haugli, and CFO, Ryan Polk, who will provide updates on the Company’s operations, recent developments, and strategic priorities. SideChannel will accept questions from investors via email before the event, which can be submitted to ir@sidechannel.com. Investors planning to attend SideChannel’s Investor Day event will need to preregister for the event by filling out an online form (https://ibn.fm/YvCR1). SideChannel is committed to creating top-tier cybersecurity programs for small and mid-sized businesses, helping them protect their data and assets, and has created over 50 multi-layered cybersecurity programs for clients. The company lends its talents to clients, creating value in the form of a bespoke cybersecurity program perfectly sized for growing enterprises. Reports have shown that cyberattacks on these types of businesses have increased in recent years due to the exponential growth of network attack surfaces. More remote and in-office workers rely on cloud environments, mobile devices, software applications, and third-party suppliers to conduct business. With this in mind, SideChannel is continually expanding its service offerings, workforce, and customer base – attracting over 20 vCISOs to serve across a vast number of industries, including fintech, biotech, healthcare, manufacturing, legal, defense, and technology services. SideChannel’s recent product offering includes Enclave(TM), a comprehensive cloud and network solution that enables IT teams to contain breaches faster, reduce network outages, minimize latency, and strengthen overall security defense. Enclave creates the foundation for a zero-trust network security model that IT can build upon, segmenting a company’s network to organize personnel and computing devices at the employee level and implement security controls across all network segments. The cybersecurity market is projected to reach $173.5 billion by the end of 2023, with security services anticipated to be the largest segment valued at $91.21 billion. The average spend per employee in the cybersecurity market is projected to reach $8,190 in 2023. The market is expected to grow at a CAGR of 10.9%, resulting in a revenue volume of $262.4 billion by 2027. Compared to global revenue, the United States is expected to account for approximately $69.7 million in 2023 (https://ibn.fm/nsWa0). Enclave was designed and purpose-built to serve the growing security needs of small to mid-sized organizations. This traditionally underserved market is more prone to cyber-attacks but has limited protection due to smaller budgets, inadequate IT security staffing, and a lack of cybersecurity awareness among top executives. SideChannel’s product is affordable and effective – shrinking the attack surface area exposed to cyber intruders and significantly reducing the effort required to operate securely. For more information, visit the company’s website at www.SideChannel.com. NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

• Bioavailability measures the amount of a substance that enters the bloodstream, with most oral routes providing lower amounts of the drug due to poor bioavailability
• Studies on nutrients show that not all the nutrients we ingest actually enter the bloodstream due to inhibiting factors in the digestive tract
• Lexaria’s patented DehydraTECH(TM) technology helps increase bioavailability for active pharmaceutical ingredients (“APIs”), which has been shown through various animal and human clinical studies

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is using its patented DehydraTECH(TM) technology to improve bioavailability and how active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery, helping with the speed of onset, and brain absorption. Lexaria is focusing ongoing research and development efforts on the advancement of product candidates across several key segments, including, nicotine replacement, CBD, cardiovascular drugs, antivirals, epilepsy, human hormones, and PDE5 inhibitors. Bioavailability measures how much of a substance enters the bloodstream, with intravenous administration being the most effective approach to 100% bioavailability for maximum effect. While oral administration is less intrusive and preferred, it presents less efficacy and bioavailability of APIs due to obstacles like gut disorders and stomach acid and liver biotransformation. Although Lexaria is focused on pharmaceutical bioavailability, it’s interesting to note that bioavailability even plays a role in nutrition. While macronutrients (carbs and fat) offer higher levels of bioavailability – micronutrients, commonly sold as supplements (vitamins, minerals, flavonoids, and carotenoids), can be harder for the body to absorb. Studies show that not all the nutrients we eat enter the bloodstream after entering the digestive tract. Some factors that affect bioavailability include where the food is grown or made, when it was harvested, how it was prepared, the foods you eat with it, and highly individualized physiological traits that affect how your body processes that food. With studies showing that around 40% of available drugs are poorly bioavailable (https://ibn.fm/xy86j), the determined factors that affect drug bioavailability include:

• The size of the drug’s molecule
• The type of drug administered
• The amount of food eaten
• The time of day the drug is taken

Understanding the bioavailability of a drug is crucial for clinicians looking for appropriate routes of administration and schedule for drug delivery. Lexaria is investigating its DehydraTECH technology for increased bioavailability of APIs with epilepsy, high blood pressure, dementia, diabetes, and more. The global pharmaceutical drug delivery market is projected to reach $2.21 billion by 2026, growing with a CAGR of 5.9% from a value of $1.66 billion in 2021. Growth is highly attributed to factors including the rising prevalence of chronic diseases, the growing biologics market, increased R&D investments, and technological advancements, which include new product launches (https://ibn.fm/cJq4l). Animal studies have also demonstrated a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery. Since 2016, Lexaria’s technology has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to ten times, reduce the onset time from one to two hours to just minutes, and mask unwanted tastes. The company’s recent study, EPIL-A21-1, demonstrated performance enhancements compared to one of the world’s leading anti-seizure medications, Epidiolex(R). The study’s results have demonstrated the performance of DehydraTECH-CBD to reduce or eliminate seizure activity in animals and, in some cases, even surpass the performance of Epidiolex. The findings from the study further support Lexaria’s efforts and clinical trials, which are currently being explored for other indications, including hypertension, dementia, and diabetes. The indications explored by Lexaria are chosen due to their current underserved medical needs, as DehydraTECH helps enhance bioavailability of substances for treatment. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Claude Bejet, a long-time precious metals investor and author of the Swiss Gold Letter, was interviewed on the sidelines of the recent Mines and Money Conference in London
• During his interview, Bejet commented on his optimism in regards to the precious metals complex as well as the considerable value held by junior mining companies
• Eloro Resources possesses a 100% option agreement on the Iska Iska deposit, a major polymetallic epithermal porphyry complex covering over 900 hectares of land
• The company is due to publish their initial assessment of Iska iska’s resource potential by March 2023, a process which Eloro are carrying out with mining consultancy, Micon International

“We’ve been through hell.” That was Claude Bejet’s succinct summary of the precious metals market and gold over the past two years. A Covid-linked downturn in 2020 was subsequently followed by an inflation-driven bear market across financial assets in 2022; although gold has historically been perceived as an inflation hedge, a rapidly appreciating US dollar – which rose by over 12% in 2022, hitting a two-decade high in September – marred what could have heralded a banner year for precious metals. However now and on the sidelines of the Mines & Money London conference, Claude Bejet expressed his belief that the worst could now be over; in an interview with industry newswire Kitco Mining, Bejet expressed his renewed optimism on the precious metals complex and commented on his optimism on the overlooked potential of listed mining companies (https://ibn.fm/WJC4x).

Marc Bristow, the CEO of Barrick Gold Corp, told investors during his keynote speech at the conference that the future of mining no longer lay in the traditional, over-explored jurisdictions of prior years. Rather, the big opportunities over the next decade would come from traditionally overlooked jurisdictions with Bolivia ranking chief amongst these. Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec has epitomised the potential success that could be derived from a focus in less traditional jurisdictions. Between 2020 and 2021, Eloro Resources witnessed its stock price rise by over 2,900% – a remarkable outcome resulting from the company’s world class silver-tin discovery with the near inexhaustible Cerro Rico mining belt (https://ibn.fm/FS9GO).

The mines around the Cerro Rico region have gained a near legendary reputation within precious mining circles, having produced approximately 2.1-3 billion ounces of silver over the past 500 years – making it the single richest source of silver in human history. In fact and between the 16^th and 18^th century, 80% of the world’s silver supply originated from the Cerro Rico region. In early 2020, Eloro Resources sought to capitalize on the region’s potential, optioning the Iska Iska project, a 484 square kilometre undeveloped mining tract within the Potosi region – a mere 180 kilometers south of the prolific Cerro Rico deposit.

Since commencing the inaugural drill program at the Iska Iska site in September 2020, Eloro Resources has drilled over 120 holes and 85,000 meters within the property, however it was their initial discoveries in late 2020 that convinced the company of the site’s relative potential. Between November 2020 and January 2021, the company found that its initial holes – most of which were between 250 and 300 meters in length, were delivering bulk tonnage of 150 silver grams equivalent per ton – a level of silver concentration which has been found to be economically viable in the past.

According to Bejet, the current equity market downturn could make for propitious timing for investors seeking to increase their allocation towards listed miners which may have been otherwise been overlooked by the market, with Eloro Resources chief amongst these. Boasting one of the most potentially significant silver and tin deposits within the Cerro Rico region and having recently looked to expand their addressable deposit size through the acquisition of the adjoining Mina Casiterita and Mina Hoyada properties, Eloro Resources may make for one of Bejet’s best bets yet.

For more information, visit the company’s website at www.EloroResources.com.

NOTE TO INVESTORS: The latest news and updates relating to ELRRF are available in the company’s newsroom at https://ibn.fm/ELRRF

World(R) on January 26-29, 2023, unites a community of international enthusiasts devoted to podcasting technology and general communication with the world through the medium of audio and video.

Main stage sponsor SiriusXM will be represented at the 9th Annual Podfest Expo(R) 2023 supporting a community of creators whos’ origin began in 2013 as a meetup of 13 attendees. This year’s expo will be topping 1500+ Podcasters enjoying an immersive experience with over 200 Subject matter experts sharing their best practices

The venue of the event is Renaissance Orlando at SeaWorld(R) – within walking distance of SeaWorld(R) Orlando and the Aquatica water park, International Drive, and Orlando’s most celebrated attractions. Enjoy the spacious hotel accommodations with resort-style amenities, Netflix streaming services and inspiring views of SeaWorld(R), to make the Podfest experience memorable.

The event is curated for new as well as seasoned podcasters. The conference topics are easy to understand and customized as per a daily agenda based on what the attendees want to learn. Podfest has plenty to offer to all categories of podcasters who are willing to learn and share their best practices. The exhibitors will be showcasing the latest technology and services in the podcasting industry.

Hosting Podfests since 2015, this conference unites important speakers on a common platform to engage, discuss, and share valuable content with the worldwide Podfest community. The speakers are dignitaries, influencers, and thought leaders, who have profound knowledge in their niche fields.

Attendees can participate and gain knowledge on industry-crucial conference topics that are available in a fully customizable agenda that attendees can tailor per their interests, including:

• Creation and Launch
• Technology and Innovation
• Audience Growth
• Monetization and Marketing
• YouTube and Video
• Networking and Social

Some of the creators presenting at Podfest Expo(R) 2023 include Sara Dean of The Shameless Mom Academy; Kate Erickson of Kate’s Take; Innovation in Compliance with Tom Fox, Bryan Green of The Commercial Break, and Larry Roberts of Red Hat Media sharing how to use Chat GPT as a creator.

To learn more, please visit www.PodFestExpo.com and https://ibn.fm/U5ZEC.

Supply chain professionals and executives in the health and pharma spectrum are invited to attend the premiere Supplier Diversity & Economic Inclusion for Pharma & Healthcare Summit, streaming online on March 7-8th, 2023. Gain important insights and actionable strategies for strengthening supply chains by committing towards diversity, equity, and inclusion.

Supplier diversity is a relatively new term in supply chain management for pharma and healthcare. There is plenty of scope and need for market leaders who can streamline supplier diversity – including procurement, sourcing, regulatory, compliance, and other areas. Discover and overcome the most critical hurdles of working with small and diverse suppliers and gain actionable tips to consolidate and engage with supply partners and expand the supplier network on a global scale.

The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries.

The event commences with the chairperson’s opening remarks followed by interactive discussion sessions on strengthening supplier diversity programs. Since finding the right supplier can be a daunting task, attendees will gain all-new insights on spending less time looking for suppliers and more time collaborating and engaging with them for effective results.

Participants will also learn about the procurement process and building capacity while understanding the process of scalability. These interactive sessions aid in overcoming misconceptions and implementing entirely different cultures to smooth out the supply chain process.

Post-lunch, experts will talk about building a strong pipeline of qualified supplier companies that can manage and operate robust supplier diversity programs.

Healthcare and pharma companies and executives can leverage this event forum to explore collaboration methods. They can learn novel strategies to engage with suppliers and apply them in their organization to drive business outcomes.

Supplier diversity programs can also aid in overcoming certification challenges. In addition, organizations can make the best use of these procurement strategies to engage with potential partners. Attendees will learn how to improve local diversity success for expanding reach globally while working to identify and partner with best-in-class diverse suppliers.

To learn more, please visit https://ibn.fm/b4soQ.

• Renewable textile innovator Coyuchi Inc. is dedicated to making luxury sustainable practice products a central part of the home living design industry
• Coyuchi’s President and CEO Eileen Mockus recently participated in a Bell2Bell podcast interview to discuss company achievements during 2022 and plans for 2023
• Coyuchi to introduce two new products in 2023 that will use cotton the company helped grow last year through a California farm focused on soil biodiversity and renewable practices
• The company’s Reg A+ investment offering, that was announced in August, already topped $1 million milestone in December

Organic luxury bed, bath, and apparel product innovator Coyuchi is celebrating the company’s new impetus for product category development and marketing thanks to enthusiasm for its Regulation A+ offering announced in August.

“One of the first use of funds that we kicked off at the end of 2022 was opening a second retail location here in Palo Alto, Calif. … That store launched just before all of the holiday selling kicked in along about mid-November and (we’re) still focusing on how do we enhance that customer experience,” company President and CEO Eileen Mockus said during a recent interview for InvestorBrandNetwork’s The Bell2Bell Podcast.

“Other things that we are working on, and we’ll have more of this coming in 2023, is looking at brand partnerships,” Mockus said. “We’re really interested in partnerships with other retailers. Seventy percent of bedding purchases are made through department stores. We’re an online business and we want to show up with other retailers.”

Those partnership goals include introducing Coyuchi’s lineup of sustainable living designs to the hospitality industry, she said.

Coyuchi has led the home industry in luxury organic textiles that have a small impact on the earth’s climate for over 30 years.

The company is pledging itself to achieve net zero emissions by 2025 and net positive emissions by 2030, and last year it announced the creation of a council of leaders with experience in the fashion, regenerative agriculture and sustainability industries to further realize its commitment.

“The complexities of the textiles supply chain do not allow for us to work alone, and when we launched our first circular product in 2020, we recognized the true value of our network in the battle against climate change,” Mockus stated at the time (https://ibn.fm/gRUeM).

As examples, Mockus noted the company’s collaboration with vendors who recycle the water in their textile processing operations and cotton growers who use renewable agriculture practices.

“(I’m) happy to share in 2022 (we) worked with a group called C4, which is the California Cotton and Climate Coalition, and grew some cotton on a farm in California, and had some great partners for that project … all looking for ways to increase biodiversity of the soil,” Mockus told Bell2Bell. “We took the cotton from that project and are launching two new products in 2023 that will use that cotton in the finished product from Coyuchi.”

Coyuchi’s original founder established the company’s goal to introduce organic cotton to the home goods sector of the textile industry, and the company has taken to heart its mission of using organic products that people will enjoy using at home, Mockus said.

The company’s net income grew 26 percent YOY between 2020 and 2021, according to an audited financial statement the company released earlier (https://ibn.fm/BitHG). The company indicated it had a return customer rate of 35 percent over 24 months, and Mockus said those returning customers were also a large part of the reason its Reg A+ offering was able to top the $1 million milestone by December 2022.

For more information, visit the company’s website at www.Coyuchi.com.

NOTE TO INVESTORS: The latest news and updates relating to Coyuchi are available in the company’s newsroom at https://ibn.fm/COYU

• Homes contribute significantly to climate change, producing twice as much carbon dioxide emissions annually than automobiles
• GeoSolar Technologies’ SmartGreen(TM) Home system utilizes leading edge solar, geothermal and air filtration technology to offer true net zero homes that achieve some of the highest HERS index ratings in the industry
• The company recently published a webinar discussing the industry while providing comprehensive insight on SmartGreen(TM) homes, from financial to health

When it comes to greenhouse gases and carbon emissions that are polluting our atmosphere and contributing to climate change, cars are usually pointed at as the major culprit. That’s not an accurate accusation, though. As detailed by GeoSolar Technologies (“GST”) in a recent webinar available on YouTube, homes produce far more carbon dioxide than cars do and it’s not even close.

The average gasoline-powered car produces 4 tons of carbon dioxide annually. The average home doubles that, generating 8 tons of carbon dioxide each year.

After a decade of R&D, the team at GeoSolar Technologies has launched the SmartGreen(TM) home, a comprehensive makeover utilizing solar panels, geothermal, and electric heat pumps to generate clean, renewable energy to heat, cool, and power a home, albeit a new build or retrofit. The result is a house with no carbon emissions or utility bills with documented health benefits for the habitants. Houses today generally are 110+ on the 0-150 HERS(R) (Home Energy Ratings System) index, indicating highly inefficient. A SmartGreen(TM) home, as one of the most efficient, environmentally friendly homes available today, registers near 0.

GeoSolar refers to the installation process, which typically only takes a couple weeks from start to finish, as “DEP,” an acronym for decarbonization, electrification, and purification. During the modernization, the house’s shell is properly insulated, and any old, inefficient heating/cooling and non-electric components of a house are removed, replaced by solar panels on the roof, geothermal ground loops, electric heat pump, EV car charger, battery backup, and air filtration system.

With a SmartGreen(TM) home, there is no need for carbon monoxide detectors or all-house generators to protect against power outages. The electrical panel is replaced by what GeoSolar calls “SPAN,” a smart energy panel that provides a full picture of energy production and consumption.

As discussed by Dr. Ty Newell, owner of Build Equinox Smart Ventilation, the attention to air quality in a SmartGreen(TM) home distinguishes it from its peers. GeoSolar’s smart ventilation continuously monitors air quality and is highly effective against COVID-19, Valley Fever, and triggers for asthma, colds, flu, and allergies. This is particularly important considering the U.S. Environmental Protection Agency estimates that indoor pollutants are often 2-5 times higher than typical outdoor concentrations. According to Dr. Newell, the GeoSolar system puts “our health, comfort, and well-being at the forefront of the technology.” The entire system can be accessed and controlled through a smartphone.

Owing in part to drastically lower costs compared to a decade ago and growing awareness of need to transition away from fossil fuels, the home electrification trend is accelerating. The Inflation Reduction Act (“IRA”), passed into law late in 2022, should serve as a catalyst for the trend, considering incentives will cover about 40% of the cost for a homeowner to ditch natural gas, propane, or heating oil in favor of renewable energy. The IRA is leading a sea change that for the first time ever makes renewable energy for the home and vehicle less expensive than fossil fuel sources.

GeoSolar and its partners take care of the complete package for homeowners. They handle all the design, permitting, installation, commissioning, rebates, and financing to make the upgrades seamless with minimal disruption to the homeowner’s lives.

The GeoSolar team members walk the walk. Dar-Long Chan, PhD, is Director of New Product Development at GeoSolar. He left a 16-year career at Exxon where he learned in detail just how dirty fossil fuel energy is. Taking the approach to “lead fossil fuels before they lead me,” he made a personal and professional career change dedicated to clean energy transition, including moving into a SmartGreen(TM) net zero home in Colorado that uses about 25% of the energy of a traditional similar-sized house.

Stone Douglas, CEO at GeoSolar, is on a similar journey, decarbonizing and electrifying his house in California over a decade ago before it was becoming trendy. Douglas says that he made the transition purely for financial reasons and that was before all the robust incentives available today. He thinks with all the rebates and tax credits of the IRA, that homeowners can realize about a 7-year return on investment and then live without a utility bill, which he calls effectively a “tax-free dividend” of the investment made in your home, health, and environment.

For more information, visit the company’s website at www.GeoSolarPlus.com.

NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST